Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $60.91
- 52-wk low
- $28.25
- Prev close
- $45.61
- Mkt cap
- $3.39B
- P/E
- 30.1x
- Fwd P/E
- 22.5x
Smart money
Earnings
Earnings came in 27.6% above what analysts expected.
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $131.9M | $140.6M | $139.1M | $150.3M |
| Cost of what it sold | $40.6M | $36.0M | $38.5M | $41.8M |
| Gross profit | $91.3M | $104.7M | $100.6M | $108.6M |
| What it spent | ||||
| Research and development | $16.0M | $20.8M | $27.1M | $29.4M |
| Sales and admin | $43.2M | $1.4M | $23.7M | $27.4M |
| Other operating costs | $9.1M | $56.5M | $26.0M | $28.7M |
| Total operating expenses | $68.3M | $78.7M | $76.7M | $85.6M |
| What was left | ||||
| Operating profit | $22.9M | $25.9M | $23.8M | $23.0M |
| Interest on debt | $0 | $0 | $0 | $0 |
| Profit before tax | $18.9M | $40.6M | $30.0M | $19.4M |
| Tax | -$248.0K | -$515.0K | $1.3M | -$6.0M |
| Net profit | $19.1M | $41.1M | $28.7M | $25.5M |
| EBITDA | $24.2M | $45.9M | $35.4M | $24.3M |
Technicals
Price structure
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
Coverage is bullish
Tone of tracked coverage
Rice Hall James & Associates LLC Invests $5.61 Million in Veracyte, Inc. $VCYT
BullishAug 18Is Veracyte (VCYT) Undervalued As Raised 2026 Outlook And Q2 Earnings Lift Interest?
Leans bullishAug 16Veracyte Inc (VCYT) Shares Fall 3.2% -- GF Value Says Still Overvalued
Leans bearishAug 14